Clinical Trial Update: Pantoprazole 20/40 mg in the Treatment of Symptomatic Reflux Disease With Focus on Sleep Disorders

View source ↗

Summary

This clinical trial update summarizes a completed study of pantoprazole 20/40 mg for symptomatic reflux disease, with a focus on sleep disorders, and results we…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-erosive Reflux Disease
• Sleep Disorders

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Nycomed | Conditions: Sleep Disorders, Non-Erosive Reflux Disease | Status: COMPLETED | Results posted: 2010-09-15